Leslie V. Norwalk, Director: Neurocrine Biosciences NBIX Planned sale · Filed 05/12

Trade details

Type: Planned sale notice
Stock: Neurocrine Biosciences NBIX
Person: Leslie V. NorwalkDirector
Planned sale date: 26/05/12
Filed: 26/05/12

$1M to be sold

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 04/12~06/11

Leslie V. Norwalk's recent trades

Leslie V. NorwalkDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$210.1K
1,250 sh
$210.1K
Filed 06/08
Traded 06/04
Leslie V. NorwalkDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$590.6K
3,810 sh
$590.6K
Filed 05/14
Traded 05/12
Leslie V. NorwalkDirector
Sell10b5-1 planGlobus Medical
Sell10b5-1 plan
Globus Medical
GMED
$202.2K
2,000 sh
$202.2K
Filed 01/12
Traded 01/08
Leslie V. NorwalkDirector
Planned sale10b5-1 planGlobus Medical
Planned sale10b5-1 plan
Globus Medical
GMED
$202K
2,000 sh
$202K
Filed 01/08
Traded 01/08
Leslie V. NorwalkDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$761.2K
5,000 sh
$761.2K
Filed 25/12/17
Traded 25/12/15

Leslie V. Norwalk, Director — plans to sell 6,310 sh of Neurocrine Biosciences NBIX · $1M · around 05/12 · 10b5-1 plan | Whalegun